AMPE
$0.48
Ampio Pharmaceuticals
($.02)
(3.03%)
AMPE
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.02)
Revenue:  N/A
Wednesday
Mar 2
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AMPE reports earnings?
Beat
Meet
Miss

Where is AMPE's stock price going from here?
Up
Flat
Down
Stock chart of AMPE
Analysts
Summary of analysts' recommendations for AMPE
Score
Grade
Pivots
Resistance
$0.52
$0.51
$0.50

$0.48

Support
$0.47
$0.46
$0.44
Tweet
Growth
Description
Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products offered by the Company include Optina, an oral drug for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug for the treatment of diabetic nephropathy. Ampio Pharmaceuticals, Inc. is based in Greenwood Village, Colorado.
Peers
Vertex PharmaceuticalsMerck & Co.Ultragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbZoetisEli LillyPfizerInterCept